This is an old revision of this page, as edited by DMacks(talk | contribs) at 04:57, 17 June 2020(out-of-scope for pattern Undid revision 962991660 by DMacks (talk)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 04:57, 17 June 2020 by DMacks(talk | contribs)(out-of-scope for pattern Undid revision 962991660 by DMacks (talk))
Pramiconazole is a triazoleantifungal which was under development by Barrier Therapeutics for the treatment of acute skin and mucosal fungal infections but was never marketed.[1]